Constitutively active MEK1 is sufficient to induce epithelial‐to‐mesenchymal transition in intestinal epithelial cells and to promote tumor invasion and metastasis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cancer

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.24485PMID 19462441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases.

  2010cited by this paper
• Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors

  2008cited by this paper
• A Review on

  2008cited by this paper
• Erratum: PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. (Cancer Res (2008) 68 (1953-61))

  2008cited by this paper
• Transitions between epithelial and mesenchymal states in development and disease.

  2008cited by this paper
• Special Topic: NF-κB, Immunity and Cancer NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

  2008cited by this paper
• Epidermal growth factor receptor‐dependent PI3K‐activation promotes restitution of wounded human gastric epithelial monolayers

  2008cited by this paper
• Is Src the key to understanding metastasis and developing new treatments for colon cancer?

  2008cited by this paper
• PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

  2008cited by this paper
• The role of epithelial-mesenchymal transition in cancer pathology.

  2007cited by this paper
• Neurotensin stimulates expression of early growth response gene‐1 and EGF receptor through MAP kinase activation in human colonic epithelial cells

  2007cited by this paper
• The role of cyclooxygenase-2 and prostaglandins in colon cancer.

  2007cited by this paper
• Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer

  2007cited by this paper
• Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer

  2007cited by this paper
• The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

  2007cited by this paper
• Fra‐1 regulates vimentin during Ha‐RAS‐induced epithelial mesenchymal transition in human colon carcinoma cells

  2007cited by this paper
• Molecular Cancer Gene Expression Profiling following Constitutive Activation of Mek1 and Transformation of Rat Intestinal Epithelial Cells

  2006cited by this paper
• Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail

  2006influential reference
• Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1

  2006cited by this paper
• Recent advances in the treatment of colon cancer.

  2006cited by this paper
• Peroxisome Proliferator-activated Receptor γ Promotes Epithelial to Mesenchymal Transformation by Rho GTPase-dependent Activation of ERK1/2*

  2006cited by this paper
• Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.

  2006cited by this paper
• Transforming growth factor-β during carcinogenesis: the shift from epithelial to mesenchymal signaling

  2006cited by this paper
• The epithelial–mesenchymal transition: new insights in signaling, development, and disease

  2006influential reference
• DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

  2005cited by this paper
• The MAPK signalling pathways and colorectal cancer.

  2005cited by this paper
• αvβ5-Integrins mediate early steps of metastasis formation

  2005cited by this paper
• Alphavbeta5-integrins mediate early steps of metastasis formation.

  2005cited by this paper
• Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.

  2005cited by this paper
• Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.

  2005cited by this paper
• Unraveling signalling cascades for the Snail family of transcription factors.

  2005cited by this paper
• Proteomic expression analysis of colorectal cancer by two‐dimensional differential gel electrophoresis

  2005cited by this paper
• Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways

  2005cited by this paper
• Protein Kinase C (PKC) βII Induces Cell Invasion through a Ras/Mek-, PKCι/Rac 1-dependent Signaling Pathway*

  2004cited by this paper
• Osteopontin regulates multiple functions contributing to human colon cancer development and progression

  2004cited by this paper
• Transcriptional regulation of cadherins during development and carcinogenesis.

  2004cited by this paper
• Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo

  2004cited by this paper
• Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells

  2004cited by this paper
• Snail Mediates E-Cadherin Repression by the Recruitment of the Sin3A/Histone Deacetylase 1 (HDAC1)/HDAC2 Complex

  2004cited by this paper
• Colorectal tumors frequently express phosphorylated mitogen‐activated protein kinase

  2004cited by this paper
• Dual role of MEK/ERK signaling in senescence and transformation of intestinal epithelial cells.

  2004influential reference
• Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids

  2004cited by this paper
• BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer

  2004cited by this paper
• Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway.

  2004cited by this paper
• Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling.

  2003cited by this paper
• Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex in colon cancer cells

  2003cited by this paper
• Osteopontin identified as colon cancer tumor progression marker.

  2003cited by this paper
• Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells

  2003cited by this paper
• The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

  2003cited by this paper
• Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.

  2003cited by this paper
• Role of MAP kinase in tumor progression and invasion

  2003cited by this paper
• RAS oncogenes: the first 30 years

  2003cited by this paper
• Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

  2003cited by this paper
• Matrix Metalloproteinases

  2003cited by this paper
• Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Regulation of life and death by the zinc finger transcription factor Egr‐1

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling.

  2002cited by this paper
• Vasopressin-mediated mitogenic signaling in intestinal epithelial cells.

  2002cited by this paper
• Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.

  2002cited by this paper
• Altered Regulation of ERK1b by MEK1 and PTP-SL and Modified Elk1 Phosphorylation by ERK1b Are Caused by Abrogation of the Regulatory C-terminal Sequence of ERKs*

  2001cited by this paper
• A New Role for E12/E47 in the Repression ofE-cadherin Expression and Epithelial-Mesenchymal Transitions*

  2001cited by this paper
• The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

  2001cited by this paper
• Tumor environment: a potent driving force in colorectal cancer?

  2001cited by this paper
• Visualization of GFP-expressing tumors and metastasis in vivo.

  2001cited by this paper
• Hydroxyurea inhibits the transactivation of the HIV‐long‐terminal repeat (LTR) promoter

  2000cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• ERK1b, a 46-kDa ERK Isoform That Is Differentially Regulated by MEK*

  2000cited by this paper
• Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation.

  2000cited by this paper
• The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells

  2000cited by this paper
• The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells.

  2000cited by this paper
• Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

  1999cited by this paper
• Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells

  1999cited by this paper
• Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis

  1999cited by this paper
• Sustained Activation of the Mitogen-activated Protein Kinase Pathway

  1999cited by this paper
• MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.

  1999cited by this paper
• Constitutively Active Mitogen-activated Protein Kinase Kinase Mek1 Disrupts Morphogenesis and Induces an Invasive Phenotype in Madin-darby Canine Kidney Epithelial Cells 1

  1999cited by this paper
• Expression and activity of mitogen activated protein kinases in human colorectal carcinoma

  1999cited by this paper
• Organization and regulation of mitogen-activated protein kinase signaling pathways.

  1999cited by this paper
• Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells.

  1999cited by this paper
• Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

  1999cited by this paper
• Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells.

  1999cited by this paper
• Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells.

  1999cited by this paper
• Tumor‐specific Activation of Mitogen‐activated Protein Kinase in Human Colorectal and Gastric Carcinoma Tissues

  1998cited by this paper
• Analysis of Signaling Protein Kinases in Human Colon or Colorectal Carcinomas

  1998cited by this paper
• Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells.

  1998cited by this paper
• Repression of mitogen‐activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins

  1998cited by this paper
• Hyperexpression of mitogen-activated protein kinase in human breast cancer.

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• The Dual Specificity Mitogen-activated Protein Kinase Phosphatase-1 and −2 Are Induced by the p42/p44MAPK Cascade*

  1997cited by this paper
• Transformation by ras modifies AP1 composition and activity

  1997cited by this paper
• L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases.

  1997cited by this paper
• Constitutively Active Mutant of the Mitogen-activated Protein Kinase Kinase MEK1 Induces Epithelial Dedifferentiation and Growth Inhibition in Madin-Darby Canine Kidney-C7 Cells*

  1997cited by this paper
• General mechanisms of metastasis

  1997cited by this paper
• Regulation of transcription by MAP kinase cascades.

  1996cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• Growth factor‐stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1)

  1994cited by this paper
• Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

  1994cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper

• Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines

  2024cites this paper
• Dietary omega-3 (ω-3) fatty acids mitigate intestinal barrier integrity alterations in mice fed a high-fat diet: Implications for pancreatic carcinogenesis.

  2024cites this paper
• Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward

  2023cites this paper
• Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence

  2023cites this paper
• An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer.

  2023cites this paper
• Translocating proteins compartment-specifically alter the fate of epithelial-mesenchymal transition in a compartmentalized Boolean network model

  2022cites this paper
• The Role of Catechins in Regulating Diabetes: An Update Review

  2022cites this paper
• Minerals and Cancer: Overview of the Possible Diagnostic Value

  2022cites this paper
• Transcriptome Landscape of Epithelial to Mesenchymal Transition of Human Stem Cell–Derived RPE

  2021cites this paper
• Targeted Protein Degradation through Fast Optogenetic Activation and Its Application to the Control of Cell Signaling.

  2021cites this paper
• KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition

  2021cites this paper
• Molecular features and gene expression signature of metastatic colorectal cancer

  2021cites this paper
• Molecular Carcinogenesis

  2020cites this paper
• NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas

  2020cites this paper
• Retracted: circSMAD2 governs migration and epithelial–mesenchymal transition by inhibiting microRNA‐9

  2019cites this paper
• Effect of STC2 gene silencing on colorectal cancer cells

  2019influential citation
• MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo

  2019cites this paper
• Elucidation of the mechanism underlying CD44v6‐induced transformation of IEC‐6 normal intestinal epithelial cells

  2019cites this paper
• (-)-Epicatechin and NADPH oxidase inhibitors prevent bile acid-induced Caco-2 monolayer permeabilization through ERK1/2 modulation

  2019cites this paper
• Distinct Transcriptional Programming Drive Response to MAPK Inhibition in BRAFV600-Mutant Melanoma Patient-Derived Xenografts

  2019cites this paper
• RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer

  2019cites this paper
• Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

  2018cites this paper
• Long non-coding RNA HULC affects the proliferation, apoptosis, migration, and invasion of mesenchymal stem cells

  2018cites this paper
• Dual‐specificity phosphatase 6 deletion protects the colonic epithelium against inflammation and promotes both proliferation and tumorigenesis

  2018cites this paper
• Therapeutic Promise of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor in a Preclinical Model of Colon Carcinogenesis

  2018cites this paper
• Dissecting Oncogenic RTK Pathways in Colorectal Cancer Initiation and Progression.

  2018cites this paper
• Targeting tumor cell plasticity by combined inhibition of NOTCH and MAPK signaling in colon cancer

  2018cites this paper
• Regulation of Nucleocytoplasmic Shuttling of the Transcriptional Regulator Human Mesoderm Induction Early Response 1 α in Breast Carcinoma Cells

  2018cites this paper
• Therapeutic targeting of tumor cell plasticity in colorectal cancer

  2018cites this paper
• Toosendanin, a natural product, inhibited TGF‐β1‐induced epithelial‐mesenchymal transition through ERK/Snail pathway

  2018cites this paper
• MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells

  2017cites this paper
• Defining the human copper proteome and analysis of its expression variation in cancers.

  2017cites this paper
• Roles of Copper-Binding Proteins in Breast Cancer

  2017cites this paper
• RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma

  2017cites this paper
• Dissecting the Role of Mixed Lineage Kinase 3 (MLK3) in Breast Cancer Invasion and Metastasis

  2017cites this paper
• Runx3 is a key modulator during the epithelial-mesenchymal transition of alveolar type II cells in animal models of BPD

  2017cites this paper
• Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations.

  2017cites this paper
• Tight Junctions and the Tumor Microenvironment

  2016cites this paper
• Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer

  2016cites this paper
• Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways.

  2016cites this paper
• MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma

  2016cites this paper
• Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.

  2015cites this paper
• Epithelial to Mesenchymal Transition (EMT) and Intestinal Tumorigenesis

  2015cites this paper
• Intestinal Tumorigenesis

  2015cites this paper
• Interplay between YB-1 and IL-6 promotes the metastatic phenotype in breast cancer cells

  2015cites this paper
• Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo-keto reductase 1B10.

  2015cites this paper
• MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP.

  2015cites this paper
• IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9

  2014cites this paper
• Collagen Triple Helix Repeat Containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells

  2014cites this paper
• Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer

  2014cites this paper
• Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions

  2014cites this paper
• Egr-1 Mediates Chronic Hypoxia-Induced Renal Interstitial Fibrosis via the PKC/ERK Pathway

  2014cites this paper
• Miceagainst Intestinal Inflammation in Epithelial Tyrosine Phosphatase SHP-2

  2014cites this paper
• Epithelial Tyrosine Phosphatase SHP-2 Protects against Intestinal Inflammation in Mice

  2013cites this paper
• Development of malignant melanoma is dependent on a switch in Embryonic Transcription Factors orchestrated by the BRAF-MAPK pathway

  2013cites this paper
• Occludin Is Involved in Adhesion, Apoptosis, Differentiation and Ca2+-Homeostasis of Human Keratinocytes: Implications for Tumorigenesis

  2013cites this paper
• Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer.

  2013cites this paper
• MEK1‐induced physiological hypertrophy inhibits chronic post‐myocardial infarction remodeling in mice

  2013cites this paper
• Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer

  2013cites this paper
• Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition

  2013cites this paper
• Overexpressed DNA-binding protein inhibitor 2 as an unfavorable prognosis factor promotes cell proliferation in nasopharyngeal carcinoma.

  2012cites this paper
• Activation of the ERK1/2 pathway by the CaMEK gene via adeno-associated virus serotype 9 in cardiomyocytes.

  2012cites this paper
• MED28 regulates MEK1‐dependent cellular migration in human breast cancer cells

  2012influential citation
• MED 28 Regulates MEK 1-Dependent Cellular Migration in Human Breast Cancer Cells

  2012influential citation
• Tight junctions in lung cancer and lung metastasis: a review.

  2012cites this paper
• Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting.

  2012cites this paper
• Epithelial-mesenchymal transition and anoikis resistance: two mechanisms promoting metastasis

  2011cites this paper
• The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells

  2011cites this paper
• Signal Transduction Pathways Mediated by Unsaturated Free Fatty Acids in Breast Cancer Cells

  2011cites this paper
• CXCL5/ENA78 increased cell migration and epithelial‐to‐mesenchymal transition of hormone‐independent prostate cancer by early growth response‐1/snail signaling pathway

  2011influential citation
• Constitutive activation of the MEK/ERK pathway inhibits intestinal epithelial cell differentiation.

  2011cites this paper
• Occludin Localizes to Centrosomes and Modifies Mitotic Entry*

  2011cites this paper
• Aloe vera Non-Decolorized Whole Leaf Extract-Induced Large Intestinal Tumors in F344 Rats Share Similar Molecular Pathways with Human Sporadic Colorectal Tumors

  2011cites this paper
• Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells.

  2010cites this paper
• The PTEN Phosphatase Controls Intestinal Epithelial Cell Polarity and Barrier Function: Role in Colorectal Cancer Progression

  2010cites this paper
• Oncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cells.

  2010influential citation
• Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths

  2010cites this paper
• The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis

  2010cites this paper
• Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.

  2010cites this paper
• Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis.

  2010cites this paper
• Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes

  2010cites this paper
• Epithelial Cell Signalling in Colorectal Cancer Metastasis

  2010influential citation